Form D · Biotechnology
Novita Therapeutics, LLC
Olathe, KS · CIK 0001467894
Offering snapshot reported Oct 21, 2013 · SEC filing
- Reported sold
- $3.16M Indefinite offering
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 6, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 26
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 21, 2013 | Amendment | $3,155,000 | No comparison | 26 | SEC filing |
| Jun 28, 2012 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jul 28, 2011 | Initial | $750,000 | No comparison | 1 | SEC filing |
| Jun 10, 2010 | Initial | $590,000 | No comparison | 9 | SEC filing |
| Nov 20, 2009 | Initial | $250,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-180424
Source: Form D, filed Oct 21, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| F. Nicholas Franano | Executive |
| William P. Whitaker | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1090 S. Clay Blair Blvd. Suite 200
Olathe, KS, 66061
Olathe, KS, 66061